Cargando…

Serum cold-inducible RNA-binding protein levels as a potential biomarker for systemic sclerosis-associated interstitial lung disease

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by fibrotic, inflammatory, and vascular dysfunction. Danger-associated molecular patterns (DAMPs)-mediated inflammasome activation has been reported to be involved in the pathogenesis of SSc. Cold-inducible RNA-binding protein (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omori, Issei, Sumida, Hayakazu, Sugimori, Ayaka, Sakakibara, Moe, Urano-Takaoka, Mariko, Iwasawa, Okuto, Saito, Hinako, Matsuno, Ai, Sato, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050418/ https://www.ncbi.nlm.nih.gov/pubmed/36977758 http://dx.doi.org/10.1038/s41598-023-32231-1

Ejemplares similares

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
por: URANO-TAKAOKA, Mariko, et al.
Publicado: (2022)

Bitter taste receptor T2R38 is expressed on skin-infiltrating lymphocytes and regulates lymphocyte migration
por: Sakakibara, Moe, et al.
Publicado: (2022)

Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis
por: Hara, Mariko, et al.
Publicado: (2023)

Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study
por: Matsuda, Kazuki M., et al.
Publicado: (2019)

A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
por: Noda, Shinji, et al.
Publicado: (2012)

Recent advances in roles of G-protein coupled receptors in intestinal intraepithelial lymphocytes
por: SUMIDA, Hayakazu
Publicado: (2020)

Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
por: Yamakawa, Hideaki, et al.
Publicado: (2016)

Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease
por: Kuzumi, Ai, et al.
Publicado: (2021)

G-Protein Coupled Receptor 18 Contributes to Establishment of the CD8 Effector T Cell Compartment
por: Sumida, Hayakazu, et al.
Publicado: (2018)

GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment
por: Wang, Xiaoming, et al.
Publicado: (2014)

A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid Arthritis Overlap Syndrome
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
por: Sato, Shinji, et al.
Publicado: (2014)

Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease
por: Ohgushi, Migiwa, et al.
Publicado: (2021)

Congenital midline sinus of the upper lip: Evaluating the use of ultrasonography
por: Akatsuka, Taro, et al.
Publicado: (2022)

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis
por: Ikeda, Satoshi, et al.
Publicado: (2020)

Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
por: Kuwana, Masataka, et al.
Publicado: (2022)

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
por: Matsuno, Osamu
Publicado: (2012)

A Retrospective Study of the Clinical, Radiological, and Pathological Characteristics of Patients with Interstitial Pneumonia Preceding Rheumatoid Arthritis
por: Sato, Midori, et al.
Publicado: (2022)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis
por: Kanno, Yosuke, et al.
Publicado: (2017)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions
por: Miyauchi, Kenichiro, et al.
Publicado: (2021)

Gross and histological lesions in the livers of sika deer with particular emphasis on fascioliasis
por: MATSUDA, Kazuya, et al.
Publicado: (2019)

Nwd1 Regulates Neuronal Differentiation and Migration through Purinosome Formation in the Developing Cerebral Cortex
por: Yamada, Seiya, et al.
Publicado: (2020)

Interstitial pregnancy after ipsilateral salpingectomy: Report of a case and discussion of the possible migration route
por: Ota, Tsuyoshi, et al.
Publicado: (2017)

Treatment and relapse of interstitial lung disease in nivolumab‐treated patients with non–small cell lung cancer
por: Sata, Masafumi, et al.
Publicado: (2021)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer
por: Saito, Yoshinobu, et al.
Publicado: (2021)

Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States
por: Fan, Yanni, et al.
Publicado: (2020)

Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report
por: Sato, Yozo, et al.
Publicado: (2021)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
por: Yamaya, Takafumi, et al.
Publicado: (2022)

Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity
por: Chino, Haruka, et al.
Publicado: (2019)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qbh80k6dog9dc7rv0shl8bn9g